The FASEB Journal, Vol 1, 125-128, Copyright © 1987 by The Federation of American Societies for Experimental Biology

RESEARCH COMMUNICATIONS

Proliferation of a human epidermal tumor cell line stimulated by urokinase

JC Kirchheimer, J Wojta, G Christ and BR Binder

Several tumor cells secrete significantly increased amounts of the plasminogen activator urokinase, a trypsinlike serine protease, whose biological function in tumor biology is unclear. In this study we report that cells of the human epidermal tumor cell line CCL 20.2 express about 80,000 high-affinity urokinase receptors per cell that bind active as well as diisopropylfluorophosphate-treated high- molecular-weight (HMW) urokinase. Low-molecular-weight (LMW) urokinase is not bound to the receptor. Occupation of these receptors by active HMW urokinase stimulates cell proliferation independently in the presence of plasminogen in the culture medium. LMW urokinase has again no effect on cell proliferation. Calculated on a molar basis, this effect is about 28% of that of epidermal growth factor. Active HMW urokinase might therefore provide an autocrine receptor-mediated growth- promoting mechanism for tumor cells similar to those described for other growth factors.

This article has been cited by other articles:

				S. C. Bryer and T. J. Koh The urokinase-type plasminogen activator receptor is not required for skeletal muscle inflammation or regeneration Am J Physiol Regulatory Integrative Comp Physiol, September 1, 2007; 293(3): R1152 - R1158. [Abstract] [Full Text] [PDF]

				A. Del Rosso, M. Cinelli, S. Guiducci, A. Pignone, G. Fibbi, F. Margheri, A. Gabrielli, R. Giacomelli, A. Coppini, M. Del Rosso, et al. Deflazacort modulates the fibrinolytic pattern and reduces uPA-dependent chemioinvasion and proliferation in rheumatoid arthritis synoviocytes Rheumatology, October 1, 2005; 44(10): 1255 - 1262. [Abstract] [Full Text] [PDF]

				M. Schmidt and P. Grunsfelder Urokinase-Type Plasminogen Activator Expression and Proliferation Stimulation in Head and Neck Squamous Cell Carcinoma In Vitro and In Situ Arch Otolaryngol Head Neck Surg, June 1, 2001; 127(6): 679 - 682. [Abstract] [Full Text] [PDF]

				J.-C. ZHANG, K. CLAFFEY, R. SAKTHIVEL, Z. DARZYNKIEWICZ, D. E. SHAW, J. LEAL, Y.-C. WANG, F.-M. LU, and K. R. MCCRAE Two-chain high molecular weight kininogen induces endothelial cell apoptosis and inhibits angiogenesis: partial activity within domain 5 FASEB J, December 1, 2000; 14(15): 2589 - 2600. [Abstract] [Full Text]

				A. HAJ-YEHIA, T. NASSAR, B. S. SACHAIS, A. KUO, K. BDEIR, A. B. AL-MEHDI, A. MAZAR, D. B. CINES, and A. A.-R. HIGAZI Urokinase-derived peptides regulate vascular smooth muscle contraction in vitro and in vivo FASEB J, July 1, 2000; 14(10): 1411 - 1422. [Abstract] [Full Text]

				J. A. A. Ghiso, K. Kovalski, and L. Ossowski Tumor Dormancy Induced by Downregulation of Urokinase Receptor in Human Carcinoma Involves Integrin and MAPK Signaling J. Cell Biol., October 4, 1999; 147(1): 89 - 104. [Abstract] [Full Text] [PDF]

				J. M. Beck, A. M. Preston, and M. R. Gyetko Urokinase-Type Plasminogen Activator in Inflammatory Cell Recruitment and Host Defense against Pneumocystis carinii in Mice Infect. Immun., February 1, 1999; 67(2): 879 - 884. [Abstract] [Full Text] [PDF]

				J. L. Koopman, J. Slomp, A. C. W. de Bart, P. H. A. Quax, and J. H. Verheijen Mitogenic Effects of Urokinase on Melanoma Cells Are Independent of High Affinity Binding to the Urokinase Receptor J. Biol. Chem., December 11, 1998; 273(50): 33267 - 33272. [Abstract] [Full Text] [PDF]

				M. Li, E. G. Karakji, R. Xing, J. N. Fryer, J. A. Carnegie, S. A. Rabbani, and B. K. Tsang Expression of Urokinase-Type Plasminogen Activator and Its Receptor during Ovarian Follicular Development Endocrinology, July 1, 1997; 138(7): 2790 - 2799. [Abstract] [Full Text] [PDF]

				J. Turck, A. S. Pollock, L. K. Lee, H.-P. Marti, and D. H. Lovett Matrix Metalloproteinase 2(Gelatinase A) Regulates Glomerular Mesangial Cell Proliferation and Differentiation J. Biol. Chem., June 21, 1996; 271(25): 15074 - 15083. [Abstract] [Full Text] [PDF]

				J. L. Dickinson, E. J. Bates, A. Ferrante, and T. M. Antalis Plasminogen Activator Inhibitor Type 2 Inhibits Tumor Necrosis Factor alpha-induced Apoptosis J. Biol. Chem., November 17, 1995; 270(46): 27894 - 27904. [Abstract] [Full Text] [PDF]

				C.-I W. Q. Y. and Charles S. Craik and C. I. Wang Isolation of a High Affinity Inhibitor of Urokinase-type Plasminogen Activator by Phage Display of Ecotin J. Biol. Chem., May 19, 1995; 270(20): 12250 - 12256. [Abstract] [Full Text] [PDF]

				L. Naldini, E. Vigna, A. Bardelli, A. Follenzi, F. Galimi, and P. M. Comoglio Biological Activation of pro-HGF (Hepatocyte Growth Factor) by Urokinase Is Controlled by a Stoichiometric Reaction J. Biol. Chem., January 13, 1995; 270(2): 603 - 611. [Abstract] [Full Text] [PDF]

				C. Chen, B Lyons-Giordano, G. Lazarus, and P. Jensen Differential expression of plasminogen activators and their inhibitors in an organotypic skin coculture system J. Cell Sci., January 9, 1993; 106(1): 45 - 53. [Abstract] [PDF]

				O. Shliom, M. Huang, B. Sachais, A. Kuo, J. W. Weisel, C. Nagaswami, T. Nassar, K. Bdeir, E. Hiss, S. Gawlak, et al. Novel Interactions between Urokinase and Its Receptor J. Biol. Chem., August 4, 2000; 275(32): 24304 - 24312. [Abstract] [Full Text] [PDF]